Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators

Table 3

Risk ratios and 95% confidence intervals for all-cause mortality based on GFR.

GFR (mL/min/1.73 m^2)	𝑛^{	Death (%)	Unadjusted	Adjusted*
≥60	278	11.9	ref	ref
30–59	172	22.5	1.89 (1.24–2.90)	1.81 (1.18–2.78)
<30	32	57.1	4.81 (3.13–7.40)	4.63 (3.02–7.09)

*Adjusted for age (≥75 or <75 years), sex, indication for ICD implantation (primary/secondary), NYHA class, antiarrhythmics, ace inhibitor, digoxin, aldosterone blocker, and betablocker use and LVEF (<30%, ≥30%).
{Followup data not available in 27 patients.